Today: 5 June 2026

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Milestone Pharmaceuticals (MIST) Stock in Focus on Dec. 12, 2025: FDA Decision Countdown, Latest News, Analyst Forecasts, and Key Risks

Milestone Pharmaceuticals (MIST) Stock in Focus on Dec. 12, 2025: FDA Decision Countdown, Latest News, Analyst Forecasts, and Key Risks

Milestone Pharmaceuticals shares closed at $2.95 on Dec. 11, up 10.49% with about 7.54 million shares traded, ahead of an FDA decision on CARDAMYST nasal spray for PSVT due Dec. 13. The stock traded around $2.98 pre-market Dec. 12, rebounding from a 52-week low of $0.625 after an FDA rejection earlier in 2025 and subsequent resubmission.
12 December 2025
Centene (CNC) Stock News, Forecasts and Analysis on December 12, 2025: Why Shares Rebounded Near $40 and What Comes Next

Centene (CNC) Stock News, Forecasts and Analysis on December 12, 2025: Why Shares Rebounded Near $40 and What Comes Next

Centene shares closed at $40.46 on December 11, up 4.6% after Baird raised its price target to $36 while keeping a Neutral rating. The stock remains 39% below its 52-week high. Uncertainty persists over expiring ACA premium subsidies, with no Senate deal reported as of December 11. Policy risk and Medicaid margins continue to weigh on investor sentiment.
12 December 2025
SMX Stock News Today (Dec. 12, 2025): Security Matters Shares Swing on Cotton Traceability Breakthrough and $116.5M Financing Updates (NASDAQ: SMX)

SMX Stock News Today (Dec. 12, 2025): Security Matters Shares Swing on Cotton Traceability Breakthrough and $116.5M Financing Updates (NASDAQ: SMX)

SMX (NASDAQ: SMX) shares surged 45.64% to close at $213.07 on Thursday, then traded as high as $248.72 in early pre-market Friday. The moves follow SMX’s announcement of a cotton traceability pilot and new “proof-as-currency” supply-chain messaging. The company is also navigating updated financing terms that could alter its share count. Trading remained volatile with wide intraday swings.
12 December 2025
Cronos Group Inc (CRON) Stock Surges as US Marijuana Rescheduling Buzz Returns — Latest News, Forecasts, and Key Catalysts (Dec. 12, 2025)

Cronos Group Inc (CRON) Stock Surges as US Marijuana Rescheduling Buzz Returns — Latest News, Forecasts, and Key Catalysts (Dec. 12, 2025)

Cronos Group shares jumped as much as 19% in premarket trading Dec. 12 after reports that President Trump may seek to reclassify marijuana as a Schedule III drug. Reuters and other outlets cited broad gains across cannabis stocks on the news. Cronos recently announced a strategic acquisition in the Netherlands, aiming for top market share in Europe's largest adult-use market. No final decisions on U.S. policy have been confirmed.
RH Stock News Today (Dec. 12, 2025): Q3 Earnings, 2025 Guidance, Analyst Price-Target Cuts, and What’s Next for RH (NYSE :RH )

RH Stock News Today (Dec. 12, 2025): Q3 Earnings, 2025 Guidance, Analyst Price-Target Cuts, and What’s Next for RH (NYSE :RH )

RH shares traded around $153 on Friday after the company reported third-quarter net revenue of $883.81 million and net income of $36.27 million, both up year-over-year. The stock saw sharp swings between $151.71 and $162.00 following the results and analyst price-target cuts. RH cited the “worst housing market in almost 50 years” and ongoing tariff disruptions in its outlook. Shares remain down about 60% year-to-date.
12 December 2025
Cronos Group Inc (CRON) Stock Surges as US Marijuana Rescheduling Buzz Returns — Latest News, Forecasts, and Key Catalysts (Dec. 12, 2025)

Cronos Group Inc (CRON) Stock Surges as US Marijuana Rescheduling Buzz Returns — Latest News, Forecasts, and Key Catalysts (Dec. 12, 2025)

Cronos Group shares jumped as much as 19% in premarket trading December 12 after reports said the Trump administration may seek to reclassify marijuana as a Schedule III drug. The move follows Cronos’ recent acquisition in the Netherlands, aimed at securing top market share in Europe’s largest adult-use cannabis market. No final U.S. policy decisions have been made.
12 December 2025
Applied Therapeutics (APLT) Stock News Today: Cycle Deal Details, CVR Upside, and Analyst Outlook (Dec. 12, 2025)

Applied Therapeutics (APLT) Stock News Today: Cycle Deal Details, CVR Upside, and Analyst Outlook (Dec. 12, 2025)

Applied Therapeutics shares fell about 35% premarket to $0.14 after announcing a deal to be acquired by Cycle Pharmaceuticals. The offer includes $0.088 per share in cash and a non-transferable contingent value right tied to future FDA approvals and sales milestones. The transaction is expected to close in Q1 2026, pending a majority tender. No financing condition is attached to the merger.
Vertiv (VRT) Stock News Today (Dec. 12, 2025): Malaysia Factory Expansion, Analyst Forecasts, and What Could Move Shares Next

Vertiv (VRT) Stock News Today (Dec. 12, 2025): Malaysia Factory Expansion, Analyst Forecasts, and What Could Move Shares Next

Vertiv Holdings Co. said Friday it will open a new manufacturing facility in Johor, Malaysia, targeting rising demand for AI-ready data center equipment. Shares traded near $178.66, down 1.8%. The company expects the site to be operational by early 2026 and to create up to 500 jobs. Analysts remain divided on Vertiv’s valuation after a strong run linked to AI infrastructure spending.
12 December 2025
Hecla Mining (HL) Stock Surges as Silver Nears Record Highs and S&P MidCap 400 Inclusion Looms — News, Forecasts, and Outlook (Dec. 12, 2025)

Hecla Mining (HL) Stock Surges as Silver Nears Record Highs and S&P MidCap 400 Inclusion Looms — News, Forecasts, and Outlook (Dec. 12, 2025)

Hecla Mining shares traded near $19.35 early Friday after silver prices hit $63.67 an ounce, just below a record, and more than doubled in 2025. The company will join the S&P MidCap 400 Index before Dec. 22. Parvin Asset Management increased its stake in Hecla by 64.6%, with institutional ownership near 63%.
PetMed Express (PETS) Stock: $4 Takeover Proposal Sparks Surge — News, Forecasts, and Key Risks on Dec. 12, 2025

PetMed Express (PETS) Stock: $4 Takeover Proposal Sparks Surge — News, Forecasts, and Key Risks on Dec. 12, 2025

PetMed Express shares surged 68% to close at $2.98 Thursday after confirming an unsolicited, non-binding $4-per-share cash buyout proposal from Singapore’s SilverCape Investments. Trading volume topped 105 million shares, far above average. SilverCape disclosed its offer in an SEC filing and owns about 12% of PetMed. The board is reviewing the bid; no shareholder action is required yet.
Costco Stock (COST) Today: Earnings Beat, Membership Momentum, Tariff Lawsuit Headlines, and Fresh Wall Street Forecasts (Dec. 12, 2025)

Costco Stock (COST) Today: Earnings Beat, Membership Momentum, Tariff Lawsuit Headlines, and Fresh Wall Street Forecasts (Dec. 12, 2025)

Costco reported Q1 fiscal 2026 earnings of $4.50 per share and total revenue of $67.3 billion, beating analyst estimates. Net sales rose 8.2% to $66 billion, with membership fees up to $1.33 billion. Shares dipped slightly after hours despite the beat, as investors weighed the stock’s high valuation. Comparable sales climbed 6.4%, led by 9% adjusted growth in Canada.
Rezolute (RZLT) Stock Update Dec. 12, 2025: Phase 3 sunRIZE Miss Sparks Selloff, Analysts Reset Targets, and 2026 Catalysts

Rezolute (RZLT) Stock Update Dec. 12, 2025: Phase 3 sunRIZE Miss Sparks Selloff, Analysts Reset Targets, and 2026 Catalysts

Rezolute shares plunged 87% to around $1.40 on December 12, 2025, after its Phase 3 sunRIZE trial for ersodetug in congenital hyperinsulinism failed to meet primary or key secondary endpoints. The trial enrolled 63 patients; efficacy differences versus placebo were not statistically significant. Two serious hypersensitivity reactions were reported. Rezolute plans to meet with the FDA under Breakthrough Therapy Designation.
12 December 2025
Paranovus Entertainment Technology Ltd (PAVS) Stock: Latest News, SEC Filings, Earnings Takeaways, and Forecasts for December 12, 2025

Paranovus Entertainment Technology Ltd (PAVS) Stock: Latest News, SEC Filings, Earnings Takeaways, and Forecasts for December 12, 2025

Paranovus Entertainment Technology Ltd. (NASDAQ: PAVS) traded around $0.03–$0.04 on December 12, 2025, with sharp swings in pre-market and extended hours. The company reported $12.41 million in revenue for the six months ended September 30, but filings show mixed profitability. Investors are watching a $200 million shelf registration and a Nasdaq bid-price compliance deadline on January 7, 2026.
Aurora Cannabis (ACB) Stock Jumps on US Marijuana Rescheduling Headlines: Today’s News, Forecasts, and Analysis (Dec. 12, 2025)

Aurora Cannabis (ACB) Stock Jumps on US Marijuana Rescheduling Headlines: Today’s News, Forecasts, and Analysis (Dec. 12, 2025)

Aurora Cannabis (ACB) jumped about 15% in pre-market trading Friday after reports that President Trump may direct agencies to reclassify marijuana as a Schedule III drug. The White House said no final decisions have been made. Investors responded to the potential for eased penalties and tax burdens. Aurora closed at $4.55 on Dec. 11 and was indicated near $5.30 early Friday.
12 December 2025
Medical Properties Trust (MPW) Stock News on Dec. 12, 2025: Dividend Hike, $150M Buyback, Analyst Targets, and What Investors Are Watching

Medical Properties Trust (MPW) Stock News on Dec. 12, 2025: Dividend Hike, $150M Buyback, Analyst Targets, and What Investors Are Watching

Medical Properties Trust shares fell from $5.51 to $5.13 after the stock went ex-dividend on Dec. 11, 2025, and traded near $5.16 premarket Friday. The company raised its quarterly dividend to $0.09 per share and approved a $150 million share repurchase plan. CEO Edward Aldag cited improving cash flow and rent collections. Elevated leverage and tenant risks remain concerns.
12 December 2025
Carnival Corporation & plc Stock (CCL) Jumps Ahead of Q4 Earnings: Dec. 12, 2025 News, Analyst Forecasts, and What Investors Are Watching

Carnival Corporation & plc Stock (CCL) Jumps Ahead of Q4 Earnings: Dec. 12, 2025 News, Analyst Forecasts, and What Investors Are Watching

Carnival shares jumped to $27.84 on Dec. 12, 2025, ahead of next week’s quarterly results and fiscal 2026 guidance. The stock rallied after the Federal Reserve cut rates to 3.50%–3.75% on Dec. 10, easing pressure on debt-heavy travel firms. Carnival’s Q4 earnings call is set for Dec. 19, with analysts expecting EPS of $0.24 on $6.38 billion revenue.
Disney Stock (DIS) News, Forecasts and Analysis: OpenAI Sora Deal, Google Copyright Clash, and What’s Next for Shares (Dec. 12, 2025)

Disney Stock (DIS) News, Forecasts and Analysis: OpenAI Sora Deal, Google Copyright Clash, and What’s Next for Shares (Dec. 12, 2025)

Disney shares rose 2.4% to $111.46 after the company announced a $1 billion investment in OpenAI and a three-year deal to license over 200 characters for AI-generated videos. Disney also sent Google a cease-and-desist letter alleging copyright infringement by its generative AI tools. The OpenAI agreement excludes talent likenesses and awaits final approval.
Dollar Tree (DLTR) Stock News Today: Shares Near 52-Week High as Earnings Beat, Guidance Rises, and Wall Street Splits on the 2026 Outlook

Dollar Tree (DLTR) Stock News Today: Shares Near 52-Week High as Earnings Beat, Guidance Rises, and Wall Street Splits on the 2026 Outlook

Dollar Tree shares closed at $129.97 on Dec. 11, up 4.61%, after posting its highest level in over a year. The stock has gained about 15% since Dec. 3, following strong Q3 results, raised 2025 guidance, and the completed sale of Family Dollar. Net sales rose 9.4% to $4.7 billion, with same-store sales up 4.2%. Management cited higher average ticket and a shift to a multi-price strategy.
Katapult Holdings (KPLT) Stock Surges on Aaron’s–CCF All-Stock Deal: Latest News, Forecasts, and Analyst Views (Dec. 12, 2025)

Katapult Holdings (KPLT) Stock Surges on Aaron’s–CCF All-Stock Deal: Latest News, Forecasts, and Analyst Views (Dec. 12, 2025)

Katapult Holdings announced a definitive all-stock merger with The Aaron's Company and CCF Holdings, aiming to form a larger omni-channel platform for non-prime consumers. After closing, expected in the first half of 2026, Katapult shareholders will own 6% of the combined company. The new entity will keep the Katapult name and Nasdaq ticker, with headquarters in Atlanta. Aaron's CEO Cory Miller will lead the merged company.
12 December 2025
1 472 473 474 475 476 587

Stock Market Today

  • Sensex, Nifty Slip Marginally Post-RBI Policy; Banking Stocks Lead Gains
    June 5, 2026, 7:09 AM EDT. Indian markets ended June 5 with marginal losses after the Reserve Bank of India (RBI) held the repo rate at 5.25% and kept a neutral stance. The central bank lowered FY27 GDP growth forecast to 6.6% and raised inflation estimate to 5.1%. The Sensex fell 0.16% to 74,243.34, Nifty lost 0.21% to 23,366.70, with both down 0.7% for the week. The Indian rupee gained strength, closing at 94.94 per dollar. Sectorally, Media and PSU Banks outperformed, while Energy, IT, and Telecom declined. Over 120 BSE stocks hit 52-week highs, including Adani Energy and CG Power. Individual movers included Bluspring Enterprises rising 10% on a major contract win, and Lupin and Aurobindo Pharma advancing on USFDA approvals. InterGlobe Aviation shares dropped after suspending some international flights.

Latest articles

Merlin Moves Higher in Premarket After U.S. Military Clears Next Flight-Test

Merlin Moves Higher in Premarket After U.S. Military Clears Next Flight-Test

5 June 2026
Merlin Inc shares soared up to 27.6% premarket after announcing its C-130J autonomy program with U.S. Special Operations Command cleared a Critical Design Review, moving the $100M+ IDIQ contract toward integration and testing; investors reacted to this key milestone as Merlin, newly public and early-revenue, is closely watched for hardware execution amid a volatile stock history and limited margin for error.
Nasdaq Futures Down With Broadcom Surprise Ahead of Jobs Report

Nasdaq Futures Down With Broadcom Surprise Ahead of Jobs Report

5 June 2026
Broadcom’s second-quarter revenue miss and lower-than-expected AI chip forecast sent Nasdaq 100 futures down 0.91% and S&P 500 futures off 0.41% premarket, as investors cut exposure to AI-linked stocks ahead of the May jobs report, intensifying pressure on chipmakers and raising the stakes for Friday’s labor data.
Lululemon Shares Drop Premarket as U.S. Weakness Persists

Lululemon Shares Drop Premarket as U.S. Weakness Persists

5 June 2026
Lululemon shares plunged about 12% premarket after slashing its annual profit forecast and issuing a weak Q2 earnings outlook, erasing over $1.7 billion in value as North American demand falters, margins shrink, and analysts warn of further pressure unless the brand and product offerings improve.
Redwire Shares Jump After Space Strawberries, But Backlog Questions Remain

Redwire Shares Jump After Space Strawberries, But Backlog Questions Remain

5 June 2026
Redwire surged 15.1% to $21.43 after landing a contract to grow wild strawberries on the ISS using its commercial space greenhouse, adding nearly $600 million in market value amid volatile space stocks; a separate $15.9 million Army drone award also boosted defense exposure, but no value was disclosed for the greenhouse deal.
Social Security Payments Face $500 Monthly Cut by 2032, All States Affected

Social Security Payments Face $500 Monthly Cut by 2032, All States Affected

5 June 2026
A new watchdog report warns Social Security retirement benefits could be slashed by 24%—about $500 a month on average—if Congress fails to act before the trust fund runs dry in late 2032, with the next annual trustees report due in weeks set to reset the solvency clock for tens of millions of Americans.
Go toTop